Our prior plasma proteomics identified elevated C-C motif chemokine ligand 14 (CCL14) in LAM, yet its role remains unexplored.<h4>Methods</h4>Proteomic analysis identified CCL14 as differentially expressed in LAM patients versus healthy controls. The gene discussed is CCL14; the disease is lymphangioleiomyomatosis.